Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 3Unknown 2Completed 2Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombocythemia, Essential 1Polycythemia Vera 1Hypogonadism 1Fatigue Syndrome, Chronic 1Eunuchism 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Drug Evaluation × Clear all
NCT04049331 2026-04-22

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Seattle Institute for Biomedical and Clinical Research

Phase 2 Active not recruiting
240 enrolled

Eunuchism, Hypogonadism, Fatigue Syndrome, Chronic

NCT02577926 2025-06-10

Ruxo-BEAT

RWTH Aachen University

Phase 2 Active not recruiting
207 enrolled
Myeloid

Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon âš¡